Edition:
United States

Ultragenyx Pharmaceutical Inc (RARE.OQ)

RARE.OQ on NASDAQ Stock Exchange Global Select Market

52.21USD
16 Jan 2019
Change (% chg)

-- (--)
Prev Close
$52.21
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
222,474
52-wk High
$90.95
52-wk Low
$37.98

Consensus Recommendations

Consensus Recommendation Next Earnings (approx.) Company Fiscal Year
End Month
Last Updated
Outperform -1.87 December 17 Jan 2019

Analyst Recommendations and Revisions

1-5 Linear Scale Current 1 Month
Ago
2 Month
Ago
3 Month
Ago
(1) BUY 7 7 7 7
(2) OUTPERFORM 7 8 8 8
(3) HOLD 6 5 5 4
(4) UNDERPERFORM 0 0 0 0
(5) SELL 0 0 0 1
No Opinion 0 0 0 0
Mean Rating 1.95 1.90 1.90 2.00

Consensus Estimates Analysis

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
  # of Estimates Mean High Low 1 Year
Ago
SALES (in millions)
Quarter Ending Mar-19 9 15.07 19.20 10.39 --
Quarter Ending Jun-19 9 19.28 25.30 16.10 --
Year Ending Dec-19 18 101.92 146.00 73.00 91.59
Earnings (per share)
Quarter Ending Mar-19 9 -1.87 -1.66 -2.12 --
Quarter Ending Jun-19 9 -1.83 -1.52 -2.11 --
Year Ending Dec-19 19 -6.61 -4.79 -8.39 -5.96

Historical Surprises

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
Estimates vs Actual Estimate Actual Difference Surprise %
SALES (in millions)
Quarter Ending Sep-18 11.35 11.76 0.41 3.62
Quarter Ending Jun-18 5.42 12.79 7.37 135.88
Quarter Ending Mar-18 52.86 10.68 42.18 79.80
Quarter Ending Dec-17 0.18 2.41 2.23 1,230.03
Quarter Ending Sep-17 0.01 0.20 0.18 1,228.86
Earnings (per share)
Quarter Ending Sep-18 -1.96 -1.74 0.22 -11.04
Quarter Ending Jun-18 -2.09 -1.06 1.03 -49.17
Quarter Ending Mar-18 -0.19 -2.03 1.84 -970.68
Quarter Ending Dec-17 -1.99 -1.89 0.10 -5.13
Quarter Ending Sep-17 -1.86 -1.87 0.01 -0.57

Consensus Estimates Trend

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
  Current 1 Week
Ago
1 Month
Ago
2 Month
Ago
1 Year
Ago
SALES (in millions)
Quarter Ending Mar-19 15.07 15.07 15.07 15.07 --
Quarter Ending Jun-19 19.28 19.28 19.28 19.28 --
Year Ending Dec-19 101.92 101.92 101.92 101.92 91.59
Earnings (per share)
Quarter Ending Mar-19 -1.87 -1.87 -1.83 -1.84 --
Quarter Ending Jun-19 -1.83 -1.83 -1.78 -1.78 --
Year Ending Dec-19 -6.61 -6.61 -6.62 -6.62 -5.96

Estimates Revisions Summary

  Last Week Last 4 Weeks
Number Of Revisions: Up Down Up Down
Revenue
Quarter Ending Mar-19 0 0 0 0
Quarter Ending Jun-19 0 0 0 0
Year Ending Dec-19 0 0 0 0
Earnings
Quarter Ending Mar-19 0 0 1 0
Quarter Ending Jun-19 0 0 1 0
Year Ending Dec-19 0 0 2 0